Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future
Authors:
- Eiji NakamuraENEiji Nakamura
- Kikuko AmagaseKAKikuko Amagase
- Kazuyoshi TomitaKTKazuyoshi Tomita
- Teruaki FujishitaTFTeruaki Fujishita
- Kazuharu FurutaniKFKazuharu Furutani
- Susumu OkabeSOSusumu Okabe
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 98 (1) , 109-127
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- The very small-conductance K+ channel KVLQT1 and epithelial functionPflügers Archiv - European Journal of Physiology, 2000
- Antisecretory and Ulcer Healing Effects of S-0509, a Novel CCK-B/Gastrin Receptor Antagonist, in RatsDigestive Diseases and Sciences, 1999
- K V LQT channels are inhibited by the K + channel blocker 293BPflügers Archiv - European Journal of Physiology, 1997
- Genetic ablation of parietal cells in transgenic mice: a new model for analyzing cell lineage relationships in the gastric mucosa.Proceedings of the National Academy of Sciences, 1996
- Alcohol and gastric acid secretion in humans.Gut, 1993
- Gastrin and Gastric Enterochromaffin-like Cell Carcinoids in the RatDigestion, 1990
- Inhibition of gastric acid secretion in the conscious dog by the mast‐cell stabilizing agent, FPL 52694British Journal of Pharmacology, 1983
- Cimetidine—A Non-Thiourea H2-Receptor AntagonistJournal of International Medical Research, 1975
- Definition and Antagonism of Histamine H2-receptorsNature, 1972
- The effect of sodium fluoride on the output of some electrolytes from the gastric mucosa of catsThe Journal of Physiology, 1956